[JAMA] Evaluation of Aducanumab for Alzheimer Disease |
Reward10points
Best Answer
2022-3-13
|
| |
| |
10
Neurological Illness and National Security
10
Validity of Meta-Analytical Data on Cutaneous Adverse Events with Phosphoinositide 3-Kinase Inhibitors—Reply
10
Home Time Among Older Adults With Acute Myeloid Leukemia Following Chemotherapy
10
Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations
10
[Supplementary]Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock
